105 related articles for article (PubMed ID: 21500101)
1. Predictors of interest in direct-to-consumer genetic testing.
Sweeny K; Legg AM
Psychol Health; 2011 Oct; 26(10):1259-72. PubMed ID: 21500101
[TBL] [Abstract][Full Text] [Related]
2. The impact of information order on intentions to undergo predictive genetic testing: an experimental study.
Morrison V; Henderson BJ; Taylor C; A'Ch Dafydd N; Unwin A
J Health Psychol; 2010 Oct; 15(7):1082-92. PubMed ID: 20472604
[TBL] [Abstract][Full Text] [Related]
3. Areas of intervention for genetic counselling of dementia: cross-cultural comparison between Italians and Americans.
Binetti G; Benussi L; Roberts S; Villa A; Pasqualetti P; Sheu CF; Gigola L; Lussignoli G; Dal Forno G; Barbiero L; Corbellini G; Green RC; Rossini PM; Ghidoni R
Patient Educ Couns; 2006 Dec; 64(1-3):285-93. PubMed ID: 16860519
[TBL] [Abstract][Full Text] [Related]
4. Anticipated uptake of genetic testing for familial melanoma in an Australian sample: An exploratory study.
Kasparian NA; Meiser B; Butow PN; Soames Job RF; Mann GJ
Psychooncology; 2007 Jan; 16(1):69-78. PubMed ID: 16874747
[TBL] [Abstract][Full Text] [Related]
5. Australians' knowledge and perceptions of direct-to-consumer personal genome testing.
Savard J; Mooney-Somers J; Newson AJ; Kerridge I
Intern Med J; 2014 Jan; 44(1):27-31. PubMed ID: 24450520
[TBL] [Abstract][Full Text] [Related]
6. Drug information-seeking intention and behavior after exposure to direct-to-consumer advertisement of prescription drugs.
Liu Y; Doucette WR; Farris KB; Nayakankuppam D
Res Social Adm Pharm; 2005 Jun; 1(2):251-69. PubMed ID: 17138477
[TBL] [Abstract][Full Text] [Related]
7. Intention to pursue genetic testing for breast cancer among women due for screening mammography.
Gwyn K; Vernon SW; Conoley PM
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):96-102. PubMed ID: 12582018
[TBL] [Abstract][Full Text] [Related]
8. Information seeking and intentions to have genetic testing for hereditary cancers in rural and Appalachian Kentuckians.
Kelly KM; Andrews JE; Case DO; Allard SL; Johnson JD
J Rural Health; 2007; 23(2):166-72. PubMed ID: 17397374
[TBL] [Abstract][Full Text] [Related]
9. Direct-to-consumer advertising and its utility in health care decision making: a consumer perspective.
Deshpande A; Menon A; Perri M; Zinkhan G
J Health Commun; 2004; 9(6):499-513. PubMed ID: 15764449
[TBL] [Abstract][Full Text] [Related]
10. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of direct-to-consumer genetic testing for cardiovascular disease risk.
Austin SE; Hegele RA
Can J Cardiol; 2011; 27(6):682-4. PubMed ID: 21652171
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing intention to obtain a genetic test for colon cancer risk: a population-based study.
Bunn JY; Bosompra K; Ashikaga T; Flynn BS; Worden JK
Prev Med; 2002 Jun; 34(6):567-77. PubMed ID: 12052015
[TBL] [Abstract][Full Text] [Related]
13. Factors Associated with Acceptability, Consideration and Intention of Uptake of Direct-To-Consumer Genetic Testing: A Survey Study.
Stewart KFJ; Kokole D; Wesselius A; Schols AMWJ; Zeegers MP; de Vries H; van Osch LADM
Public Health Genomics; 2018; 21(1-2):45-52. PubMed ID: 30359983
[TBL] [Abstract][Full Text] [Related]
14. Reasons for not HIV testing, testing intentions, and potential use of an over-the-counter rapid HIV test in an internet sample of men who have sex with men who have never tested for HIV.
Mackellar DA; Hou SI; Whalen CC; Samuelsen K; Sanchez T; Smith A; Denson D; Lansky A; Sullivan P;
Sex Transm Dis; 2011 May; 38(5):419-28. PubMed ID: 21183863
[TBL] [Abstract][Full Text] [Related]
15. Intention to learn results of genetic testing for hereditary colon cancer.
Vernon SW; Gritz ER; Peterson SK; Perz CA; Marani S; Amos CI; Baile WF
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):353-60. PubMed ID: 10207640
[TBL] [Abstract][Full Text] [Related]
16. Community interest in predictive genetic testing for susceptibility to major depressive disorder in a large national sample.
Wilde A; Meiser B; Mitchell PB; Hadzi-Pavlovic D; Schofield PR
Psychol Med; 2011 Aug; 41(8):1605-13. PubMed ID: 21159212
[TBL] [Abstract][Full Text] [Related]
17. Facilitating informed decision making about breast cancer risk and genetic counseling among women calling the NCI's Cancer Information Service.
Miller SM; Fleisher L; Roussi P; Buzaglo JS; Schnoll R; Slater E; Raysor S; Popa-Mabe M
J Health Commun; 2005; 10 Suppl 1():119-36. PubMed ID: 16377604
[TBL] [Abstract][Full Text] [Related]
18. Women's interest in gene expression analysis for breast cancer recurrence risk.
O'Neill SC; Brewer NT; Lillie SE; Morrill EF; Dees EC; Carey LA; Rimer BK
J Clin Oncol; 2007 Oct; 25(29):4628-34. PubMed ID: 17925559
[TBL] [Abstract][Full Text] [Related]
19. A population-based survey in Australia of men's and women's perceptions of genetic risk and predictive genetic testing and implications for primary care.
Taylor S
Public Health Genomics; 2011; 14(6):325-36. PubMed ID: 21494016
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with decisions about clinical BRCA1/2 testing.
Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
